235 related articles for article (PubMed ID: 15897348)
1. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF.
Kirchmair R; Tietz AB; Panagiotou E; Walter DH; Silver M; Yoon YS; Schratzberger P; Weber A; Kusano K; Weinberg DH; Ropper AH; Isner JM; Losordo DW
Mol Ther; 2007 Jan; 15(1):69-75. PubMed ID: 17164777
[TBL] [Abstract][Full Text] [Related]
3. VEGF gene transfer for diabetic neuropathy.
Isner JM; Ropper A; Hirst K
Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
[TBL] [Abstract][Full Text] [Related]
4. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy.
Schratzberger P; Schratzberger G; Silver M; Curry C; Kearney M; Magner M; Alroy J; Adelman LS; Weinberg DH; Ropper AH; Isner JM
Nat Med; 2000 Apr; 6(4):405-13. PubMed ID: 10742147
[TBL] [Abstract][Full Text] [Related]
5. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy.
Kusano KF; Allendoerfer KL; Munger W; Pola R; Bosch-Marce M; Kirchmair R; Yoon YS; Curry C; Silver M; Kearney M; Asahara T; Losordo DW
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2102-7. PubMed ID: 15358602
[TBL] [Abstract][Full Text] [Related]
6. Reversal of experimental diabetic neuropathy by VEGF gene transfer.
Schratzberger P; Walter DH; Rittig K; Bahlmann FH; Pola R; Curry C; Silver M; Krainin JG; Weinberg DH; Ropper AH; Isner JM
J Clin Invest; 2001 May; 107(9):1083-92. PubMed ID: 11342572
[TBL] [Abstract][Full Text] [Related]
7. Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum.
Höke A; Sun HS; Gordon T; Zochodne DW
Exp Neurol; 2001 Dec; 172(2):398-406. PubMed ID: 11716563
[TBL] [Abstract][Full Text] [Related]
8. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
Yoon YS; Uchida S; Masuo O; Cejna M; Park JS; Gwon HC; Kirchmair R; Bahlman F; Walter D; Curry C; Hanley A; Isner JM; Losordo DW
Circulation; 2005 Apr; 111(16):2073-85. PubMed ID: 15851615
[TBL] [Abstract][Full Text] [Related]
9. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
10. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
Polverino A; Coxon A; Starnes C; Diaz Z; DeMelfi T; Wang L; Bready J; Estrada J; Cattley R; Kaufman S; Chen D; Gan Y; Kumar G; Meyer J; Neervannan S; Alva G; Talvenheimo J; Montestruque S; Tasker A; Patel V; Radinsky R; Kendall R
Cancer Res; 2006 Sep; 66(17):8715-21. PubMed ID: 16951187
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
Chattopadhyay M; Goss J; Wolfe D; Goins WC; Huang S; Glorioso JC; Mata M; Fink DJ
Brain; 2004 Apr; 127(Pt 4):929-39. PubMed ID: 14749293
[TBL] [Abstract][Full Text] [Related]
12. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice.
Murakami T; Arai M; Sunada Y; Nakamura A
J Gene Med; 2006 Jun; 8(6):773-81. PubMed ID: 16518878
[TBL] [Abstract][Full Text] [Related]
13. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.
Price SA; Dent C; Duran-Jimenez B; Liang Y; Zhang L; Rebar EJ; Case CC; Gregory PD; Martin TJ; Spratt SK; Tomlinson DR
Diabetes; 2006 Jun; 55(6):1847-54. PubMed ID: 16731852
[TBL] [Abstract][Full Text] [Related]
16. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
[TBL] [Abstract][Full Text] [Related]
17. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia.
Ryu JK; Cho CH; Shin HY; Song SU; Oh SM; Lee M; Piao S; Han JY; Kim IH; Koh GY; Suh JK
Mol Ther; 2006 Apr; 13(4):705-15. PubMed ID: 16380295
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
Thébaud B; Ladha F; Michelakis ED; Sawicka M; Thurston G; Eaton F; Hashimoto K; Harry G; Haromy A; Korbutt G; Archer SL
Circulation; 2005 Oct; 112(16):2477-86. PubMed ID: 16230500
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
